Next Generation in Protein Characterization
The Next Generation in Protein Characterization
The AQS3pro launches a new era in IR spectroscopy and protein characterization, bringing repeatable, high sensitivity, automated measurements to every stage of the biopharmaceutical pipeline. Powered by Microfluidic Modulation Spectroscopy (MMS), the AQS3pro measures the secondary structure of proteins over nearly four decades of concentration, from 0.1 mg/ml to over 200 mg/ml. Driven by the industry-leading AQS3delta Analytical Software package, it streamlines and simplifies 5 key measurements:
Aggregation | Quantitation | Stability | Structure | Similarity
See change in your protein, in your workflow, and in your efficiency.
Visit the product page to learn more.
Register for our upcoming webinar
Latest News
RedShiftBio Shipping AQS3pro as Industry Endorsements Expand
Photonics Media publishes article on Technological Synergies Move Spectroscopy Out of the Lab
RedShiftBio Expands Team to Support Demand for AQS3™pro
RedShiftBio’s AQS3™pro: Finalist in The Prism Awards 2019
RedShiftBio Expands Team to Support Launch of FlagShip AQS3™pro System for Protein Characterization.
Instrument Business Outlook interviews RedShiftBio CCO Jeff Zonderman on the launch of the AQS3pro.
Spectroscopy Europe highlights the launch of the AQS3pro.
RedShiftBio Launches AQS3pro Protein Characterization System.
2019 Colorado Protein Stability Conference, July 29 - Aug 1, Colorado
PEGS Europe, Nov 18-22, Lisbon
RedShiftBio™
RedShiftBio™ is an innovative provider of analytical instrumentation for the research, development and manufacturing of protein therapeutic drugs.
Awards
Contact Us
RedShift BioAnalytics Inc.
131 Middlesex Turnpike
Burlington, MA 01803
T: 781.345.7300
F: 781-345-7301
E: info@redshiftbio.com
RedShift™, RedShiftBio™, See Change™, and AQS3™ are trademarks of RedShift BioAnalytics, Inc.
Class 1 Laser Device Complies with 21 CFR Chapter 1, Subchapter J, Part 1040.10